INSIGHTS ON LIQUID DOSE MANUFACTURING
-
![GettyImages-522871505-aseptic-filling-sterile-cleanroom]( "How To Use Enzyme Indicators In An Aseptic Production Environment")
How To Use Enzyme Indicators In An Aseptic Production EnvironmentDiscover how transitioning to quantitative validation data allows engineering teams to optimize decontamination timelines, slash system downtime, and minimize product carryover risks.
-
![Minimizing Particulate Risk]( "Minimizing Particulate Risk")
Minimizing Particulate RiskWhile visible particles often draw immediate attention, visual inspection alone is insufficient, as subvisible particulate matter can pose equally significant risks to patient safety.
-
![Upperton OPCU]( "Upperton Capabilities Update April 2026: Fill/Finish")
Upperton Capabilities Update April 2026: Fill/FinishAn inside look at a modern Annex 1–compliant sterile facility designed for flexible aseptic and terminally sterilised manufacturing across multiple drug delivery routes.
-
![GettyImages-1405590436-lab-perfusion-cleanroom]( "CDMO Partnerships: Why Speed And Flexibility Matter Now More Than Ever")
CDMO Partnerships: Why Speed And Flexibility Matter Now More Than EverAs demand for GLP-1s and biologics accelerates and timelines compress, it's become more crucial that pharmaceutical companies stay competitive and bring therapies to market faster by partnering with a CDMO.
-
ADC Drug Products: Solutions To Manage Risks And Enhance Stability7/2/2026
Discover how an integrated ADC strategy addresses containment, analytics, fill-finish, and inspection challenges to improve product protection, process reliability, and delivery performance.
-
Afton Scientific Capabilities Update January 2026: Fill/Finish1/27/2026
Here, Michael Dunn outlines our current available capacity, including RABS operations, alongside the commissioning of a new Annex 1–compliant isolator filling line and expanded QC capabilities to ensure reliable, scalable execution.
-
Tank Vent And Process Gas Filters For Pharmaceutical Production6/22/2026
Air and gas filtration are essential for sterile pharma systems. Tank vent and process gas filters help prevent contamination, protect quality, and ensure reliable, efficient operations.
-
GLP-1 Peptides In Asia: Expanding Access And Opportunity9/17/2026
Asia's growing role in the GLP-1 market presents new opportunities and challenges. Learn how regulatory preparedness, scalable manufacturing, and robust quality systems can enable growth.
-
Solve ATMP Aseptic Filling Challenges With Gloveless Isolators1/9/2026
Human intervention is the top contamination risk in ATMP manufacturing. Robotic gloveless isolators address that risk through full automation and real-time monitoring during aseptic filling.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
![Monitoring GPCRs And Ion Channels With The Biomek i5 Automated Workstation]( "Monitoring GPCRs And Ion Channels With The Biomek i5 Automated Workstation")
Optimize dependability and walk-away time.
The Biomek i5 is a recent addition to our liquid handling portfolio, representing the best of what has made Biomek an industry-leading brand - combined with enhancements suggested by customers around the globe.
- Ideal for medium- to high-throughput workflows
- 25 deck positions
- 0.5 µL-1,000 µL (Multichannel) or 0.5 µL-5,000 µL (Span-8) pipetting volume ranges
- Single Multichannel head (96/384) or Span-8 pipetting with gripper
-
![stevanato-dual]( "Dual Chamber Cartridges")
Shelf life stability is one of the key challenges for sensitive drug formulations, which have witnessed continuous growth in the past few years and are projected to grow even further in the future.
-
![GettyImages-1409734937-3d-rendering-rna-dna]( "Cracking The Code Of RNA Delivery")
Advanced lipid nanoparticle strategies are transforming RNA therapeutics by enabling faster optimization, precise tissue targeting, and access to biological targets once considered unreachable.
-
![Closed-Pharmaceutical-Restricted-Access-Barrier-System]( "Closed Pharmaceutical Restricted Access Barrier System (RABS) From Franz Ziel")
Closed RABS as a housing for aseptic processes, e.g., filling, loading, and unloading of freeze dryers. Product protection is achieved through a barrier (cRABS housing with gloves) between the operator and the product.
-
![BoMas Systems]( "Pharmaceutical Liquid Filling Systems: Gels, Pastes, Suspensions")
BoMa systems allow transferring and dosing products with a complex rheology, in particular products of high viscosity. The absence of rotating seals is ideal for its use for aggressive or flammable products.
